Deferiprone to Delay Dementia (The 3D study)
Description: There are currently no drugs available to prevent or slow deterioration in Alzheimer’s disease – which is a major incurable dementia. Our recent findings demonstrate that high brain iron levels worsen brain performance and cause people to develop Alzheimer’s disease at an earlier point in time. We propose a clinical trial of deferiprone, a drug that lowers brain iron levels, to determine if this would slow deterioration in Alzheimer’s disease once it is first detected.
Amount: A$1,855,000
Funding type: research
Funder scheme: Project Grants - Standard Project Grant
Start date: 2017-01-01
End date: 2021-12-31
Investigator: Ashley Bush
Institution: Florey Institute of Neuroscience and Mental Health
Funded outputs count: 2
Funder award ID: 1123625
OpenAlex ID: G7627706346